Skip to main content
European Commission logo
Enterprise Europe Network

Israeli manufacturer of innovative wound healing and
closure solutions is looking for distributors

Summary

Profile Type
  • Business Offer
POD Reference
BOIL20230214029
Term of Validity
14 February 2023 - 13 February 2025
Company's Country
  • Israel
Type of partnership
  • Commercial agreement
Targeted Countries
  • All countries
Contact the EEN partner nearest to you for more information.
Find my local partner

General information

Short Summary
This Israeli company has developed innovative and revolutionary wound healing and closure solutions.
The technology allows for combined skin stretching and enhanced wound healing by a novel oxygen-enriched and irrigation-assisted vacuum device for early and immediate wound closure. The company is seeking partners under a distribution service agreement.
Full Description
This Israeli medical device company specializes in research, design, and development of cutting-edge wound healing and closure technologies. The company developed innovative devices and technologies that accelerate wound healing and closure. It was established in 2010 and as of today its
staff includes 6 employees.
The company developed its product after identifying the need for improving the current method of wound closure, which has limitations such as long recovery time and substantial risk of infection. The device uniquely applies a tension relief mechanism,
intended for the management of simple and complex wounds for civil, military, and mass-casualty injury applications.
The device distributes the stress on the skin away from the wound edges so that tension on the scar can be substantially reduced, thus enabling the closure of extremely hard-to-close, high-tension wounds and
improving the quality, functionality, and aesthetics of the healed wound. Through its ability to effectively stretch the skin, it reduces the need for skin grafts and flaps.
With the purpose of promoting wound healing while minimizing the risk of bleeding, the company also developed a cutting-edge, non-pharmaceutical wound healing device that applies regulated oxygen-enriched and irrigation negative pressure-assisted wound treatment (ROI-NPT) for enhancing the healing of infected, complex, and hard-to-heal wounds.
For better detection and bleeding control, the device is equipped with specially designed user-friendly software,
electronics, and alarms.
The company portfolio also includes an advanced hospital and home-use portable ROI-NPT device, improving patient ambulation and expanding its treatment arena to the growing field of home care wound therapy, including rural and low-resource settings.
The company operates under ISO 13485. The devices are FDA and CFDA approved. They are in the final stage of CE certificate renewal. The company's products were granted patents in the US, Canada, Europe, and other countries.
The company is already active overseas and exports to countries including China, Hong Kong, Kenya, and Panama.
The company wishes to expand its international activity and is therefore looking for distributors in the field of medical devices that specialize in similar products and technologies. Distributors' role would be to help the company reach its end customers: hospitals and doctors.
Advantages and Innovations
- Complies with ISO 13485, FDA, and CFDA
- The presented technologies provide breakthrough solutions in wound treatment and are the most important non-pharmaceutical physical platform technology developed and applied for wound healing in the last two decades.
- Optimal, safe, and simple wound closure, even in areas where tissue stretching is difficult.
- The solution is utilized in a broad scope of conditions in trauma, surgery, orthopedics, cardiac surgery, plastic
surgery, vascular surgery, rehabilitation, etc.
- The technology simplifies surgical procedures, shortens hospital length of stay, and reduces the need for antibiotics.
- This novel technology is intended for the management of chronic, acute, traumatic, sub-acute, and dehisced small to medium size wounds, small partial-thickness burns, and ulcers.
- Rapid recovery, the area can be moved immediately after surgery.
-The product comes in different lengths depending on the location and size of the wound
- Also suitable for animal care
Stage of Development
  • Already on the market
Sustainable Development Goals
  • Goal 3: Good Health and Well-being

Partner Sought

Expected Role of a Partner
The company wishes to further expand its international business and is therefore looking for reliable distributors. Distributors should have experience in the field of surgery,
wound healing technologies, and medical equipment supply for hospitals. The partner's role would be to help sell the company’s products to hospitals and doctors.
The potential partner could be small to medium-sized enterprises. The partners’ task would be
to increase the company’s sales in their local market.
Type and Size of Partner
  • SME <=10
  • SME 11-49
  • SME 50 - 249
Type of partnership
  • Commercial agreement

Dissemination

Technology keywords
  • 06001007 - Emergency medicine
  • 06001017 - Surgery
  • 06001013 - Medical Technology / Biomedical Engineering
Market keywords
  • 05003003 - Surgical implants
  • 05007007 - Other medical/health related (not elsewhere classified)
  • 05004006 - Surgical instrumentation and equipment
  • 05004001 - Electromedical and medical equipment
  • 05005019 - 'Surgery and Anaesthesiology
Targeted countries
  • All countries

Images